UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 47

Sortiert nach

Is Reduced First-Phase Insulin Release the Earliest Detectable Abnormality in Individuals Destined to Develop Type 2 Diabetes?

Diabetes (New York, N.Y.), 2002-02, Vol.51 (suppl 1), p.S117-S121

GERICH, John E

2002

Link zum Volltext

Verfügbarkeit prüfen

Contributions of Insulin-Resistance and Insulin-Secretory Defects to the Pathogenesis of Type 2 Diabetes Mellitus

Mayo Clinic proceedings, 2003-04, Vol.78 (4), p.447-456

Gerich, John E.

2003

Link zum Volltext

Verfügbarkeit prüfen

The Genetic Basis of Type 2 Diabetes Mellitus: Impaired Insulin Secretion versus Impaired Insulin Sensitivity

Endocrine reviews, 1998-08, Vol.19 (4), p.491-503

Gerich, John E

1998

Link zum Volltext

Verfügbarkeit prüfen

The Role of α-Cell Dysregulation in Fasting and Postprandial Hyperglycemia in Type 2 Diabetes and Therapeutic Implications

Endocrine reviews, 2007-05, Vol.28 (3), p.253-283

2007

Link zum Volltext

Verfügbarkeit prüfen

Efficacy and Safety of the Once-Daily GLP-1 Receptor Agonist Lixisenatide in Monotherapy: A randomized, double-blind, placebo-controlled trial in patients with type 2 diabetes (GetGoal-Mono)

Diabetes care, 2012-06, Vol.35 (6), p.1225-1231

2012

Link zum Volltext

Verfügbarkeit prüfen

Role of the Decrement in Intraislet Insulin for the Glucagon Response to Hypoglycemia in Humans

Diabetes care, 2005-05, Vol.28 (5), p.1124-1131

2005

Link zum Volltext

Verfügbarkeit prüfen

Effect of Aging on Glucose Homeostasis: Accelerated deterioration of β-cell function in individuals with impaired glucose tolerance

Diabetes care, 2008-03, Vol.31 (3), p.539-543

2008

Link zum Volltext

Verfügbarkeit prüfen

Increasing the Decrement in Insulin Secretion Improves Glucagon Responses to Hypoglycemia in Advanced Type 2 Diabetes

Diabetes care, 2005-11, Vol.28 (11), p.2691-2696

2005

Link zum Volltext

Verfügbarkeit prüfen

Use of Inhaled Insulin in a Basal/Bolus Insulin Regimen in Type 1 Diabetic Subjects: A 6-month, randomized, comparative trial

Diabetes care, 2005-07, Vol.28 (7), p.1630-1635

2005

Link zum Volltext

Verfügbarkeit prüfen

Efficacy and Safety of Lixisenatide Once Daily Versus Exenatide Twice Daily in Type 2 Diabetes Inadequately Controlled on Metformin: A 24-week, randomized, open-label, active-controlled study (GetGoal-X)

Diabetes care, 2013-10, Vol.36 (10), p.2945-2951

2013

Link zum Volltext

Verfügbarkeit prüfen

Diabetes mellitus and gastric emptying: questions and issues in clinical practice

Diabetes/metabolism research and reviews, 2009-09, Vol.25 (6), p.502-514

2009

Link zum Volltext

Verfügbarkeit prüfen

Clinical significance, pathogenesis, and management of postprandial hyperglycemia

Archives of internal medicine (1960), 2003-06, Vol.163 (11), p.1306

Gerich, John E

2003

Link zum Volltext

Verfügbarkeit prüfen

Metabolic abnormalities in impaired glucose tolerance

Metabolism, clinical and experimental, 1997-12, Vol.46 (12), p.40-43

Gerich, John E.

1997

Link zum Volltext

Verfügbarkeit prüfen

Multiple defects in counterregulation of hypoglycemia in modestly advanced type 2 diabetes mellitus

Metabolism, clinical and experimental, 2006-05, Vol.55 (5), p.593-598

2006

Link zum Volltext

Verfügbarkeit prüfen

The "Dawn Phenomenon": a common occurrence in both non-insulin-dependent and insulin-dependent diabetes mellitus

The New England journal of medicine, 1984-03, Vol.310 (12), p.746-750

1984

Link zum Volltext

Verfügbarkeit prüfen

Addressing the insulin secretion defect: A logical first-line approach

Metabolism, clinical and experimental, 2000-10, Vol.49 (10), p.12-16

Gerich, John E.

2000

Link zum Volltext

Verfügbarkeit prüfen

Clinical significance of postprandial hyperglycemia

Drug development research, 2006-07, Vol.67 (7), p.587-590

2006

Link zum Volltext

Verfügbarkeit prüfen

Effect of hypoglycemia on beta-adrenergic sensitivity in normal and type 1 diabetic subjects

Diabetes care, 1998-09, Vol.21 (9), p.1505

1998

Link zum Volltext

Verfügbarkeit prüfen

Diagnostic and therapeutic implications of relationships between fasting, 2-hour postchallenge plasma glucose and hemoglobin a1c values

Archives of internal medicine (1960), 2004-08, Vol.164 (15), p.1627

2004

Link zum Volltext

Verfügbarkeit prüfen

Glucose Counterregulation, Hypoglycemia, and Intensive Insulin Therapy in Diabetes Mellitus

The New England journal of medicine, 1985-07, Vol.313 (4), p.232-241

1985

Link zum Volltext

Verfügbarkeit prüfen

Insulin resistance is not necessarily an essential component of type 2 diabetes

The journal of clinical endocrinology and metabolism, 2000-06, Vol.85 (6), p.2113-2115

GERICH, J. E

2000

Link zum Volltext

Verfügbarkeit prüfen

Pathogenesis of the Dawn Phenomenon in Patients with Insulin-Dependent Diabetes Mellitus: Accelerated Glucose Production and Impaired Glucose Utilization Due to Nocturnal Surges in Growth Hormone Secretion

The New England journal of medicine, 1985-06, Vol.312 (23), p.1473-1479

1985

Link zum Volltext

Verfügbarkeit prüfen

Reversal of Hypoglycemia Unawareness in a Long-Term Type 1 Diabetic Patient by Improvement of β-Adrenergic Sensitivity after Prevention of Hypoglycemia

The journal of clinical endocrinology and metabolism, 2000-02, Vol.85 (2), p.523-525

2000

Link zum Volltext

Verfügbarkeit prüfen

Abnormal glucose counterregulation after subcutaneous insulin in insulin-dependent diabetes mellitus

The New England journal of medicine, 1984-06, Vol.310 (26), p.1706-1711

1984

Link zum Volltext

Verfügbarkeit prüfen

Demonstration of a dawn phenomenon in normal human volunteers

Diabetes (New York, N.Y.), 1984-12, Vol.33 (12), p.1150

1984

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 47

Suche als RSS-Feed

Aktive Filter

ThemaEndocrinopathies

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(44)
Mit Volltextzugriff
(34)

Publikationsform

Artikel
(47)

Sprache

Englisch
(47)
Japanisch
(12)

Erscheinungsjahr

n.n

Thema

Biological And Medical Sciences
(47)
Medical Sciences
(47)
Endocrine Pancreas. Apud Cells
(46)
Diabetes. Impaired Glucose Tolerance
(45)
Humans
(43)
Etiopathogenesis. Screening. Investigations. Target Tissue Resistance
(37)
Life Sciences & Biomedicine
(31)
Science & Technology
(31)
Adult
(26)
Male
(26)
Female
(23)
Endocrinology & Metabolism
(21)
Insulin - Blood
(21)
Blood Glucose - Metabolism
(14)
Glucose
(14)
Blood Glucose - Analysis
(13)
Diabetes
(13)
Glucagon - Blood
(13)
Middle Aged
(13)

14 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Is Reduced First-Phase Insulin Release the Earliest Detectable Abnormality in Individuals Destined to Develop Type 2 Diabetes?

Contributions of Insulin-Resistance and Insulin-Secretory Defects to the Pathogenesis of Type 2 Diabetes Mellitus

The Genetic Basis of Type 2 Diabetes Mellitus: Impaired Insulin Secretion versus Impaired Insulin Sensitivity

The Role of α-Cell Dysregulation in Fasting and Postprandial Hyperglycemia in Type 2 Diabetes and Therapeutic Implications

Efficacy and Safety of the Once-Daily GLP-1 Receptor Agonist Lixisenatide in Monotherapy: A randomized, double-blind, placebo-controlled trial in patients with type 2 diabetes (GetGoal-Mono)

Role of the Decrement in Intraislet Insulin for the Glucagon Response to Hypoglycemia in Humans

Effect of Aging on Glucose Homeostasis: Accelerated deterioration of β-cell function in individuals with impaired glucose tolerance

Increasing the Decrement in Insulin Secretion Improves Glucagon Responses to Hypoglycemia in Advanced Type 2 Diabetes

Use of Inhaled Insulin in a Basal/Bolus Insulin Regimen in Type 1 Diabetic Subjects: A 6-month, randomized, comparative trial

Efficacy and Safety of Lixisenatide Once Daily Versus Exenatide Twice Daily in Type 2 Diabetes Inadequately Controlled on Metformin: A 24-week, randomized, open-label, active-controlled study (GetGoal-X)

Diabetes mellitus and gastric emptying: questions and issues in clinical practice

Clinical significance, pathogenesis, and management of postprandial hyperglycemia

Metabolic abnormalities in impaired glucose tolerance

Multiple defects in counterregulation of hypoglycemia in modestly advanced type 2 diabetes mellitus

The "Dawn Phenomenon": a common occurrence in both non-insulin-dependent and insulin-dependent diabetes mellitus

Addressing the insulin secretion defect: A logical first-line approach

Clinical significance of postprandial hyperglycemia

Effect of hypoglycemia on beta-adrenergic sensitivity in normal and type 1 diabetic subjects

Diagnostic and therapeutic implications of relationships between fasting, 2-hour postchallenge plasma glucose and hemoglobin a1c values

Glucose Counterregulation, Hypoglycemia, and Intensive Insulin Therapy in Diabetes Mellitus

Insulin resistance is not necessarily an essential component of type 2 diabetes

Pathogenesis of the Dawn Phenomenon in Patients with Insulin-Dependent Diabetes Mellitus: Accelerated Glucose Production and Impaired Glucose Utilization Due to Nocturnal Surges in Growth Hormone Secretion

Reversal of Hypoglycemia Unawareness in a Long-Term Type 1 Diabetic Patient by Improvement of β-Adrenergic Sensitivity after Prevention of Hypoglycemia

Abnormal glucose counterregulation after subcutaneous insulin in insulin-dependent diabetes mellitus

Demonstration of a dawn phenomenon in normal human volunteers

Aktive Filter

Suchergebnisse filtern